2022-10-27 |
2022-10-25 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
3 034
-5.3%
20,10
60 996
USD
|
3 034
-5.3%
|
20,10
|
60 996
USD
|
|
2022-10-27 |
2022-10-25 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
100
-0.5%
22,13
2 213
USD
|
100
-0.5%
|
22,13
|
2 213
USD
|
|
2022-10-27 |
2022-10-25 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
2 998
-12.6%
21,42
64 215
USD
|
2 998
-12.6%
|
21,42
|
64 215
USD
|
|
2022-10-27 |
2022-10-25 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
4 942
-17.2%
20,53
101 462
USD
|
4 942
-17.2%
|
20,53
|
101 462
USD
|
|
2022-10-24 |
2022-10-24 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
1 302
-2.2%
19,66
25 595
USD
|
1 302
-2.2%
|
19,66
|
25 595
USD
|
|
2022-10-24 |
2022-10-24 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
1 102
-1.9%
18,88
20 807
USD
|
1 102
-1.9%
|
18,88
|
20 807
USD
|
|
2022-10-24 |
2022-10-24 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
1 241
-0.6%
19,65
24 380
USD
|
1 241
-0.6%
|
19,65
|
24 380
USD
|
|
2022-10-24 |
2022-10-24 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
1 101
-0.5%
18,90
20 809
USD
|
1 101
-0.5%
|
18,90
|
20 809
USD
|
|
2022-10-24 |
2022-10-21 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
2 771
-4.5%
18,29
50 668
USD
|
2 771
-4.5%
|
18,29
|
50 668
USD
|
|
2022-10-24 |
2022-10-21 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
2 786
-1.4%
18,28
50 917
USD
|
2 786
-1.4%
|
18,28
|
50 917
USD
|
|
2022-10-24 |
2022-10-20 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
905
-1.4%
18,07
16 357
USD
|
905
-1.4%
|
18,07
|
16 357
USD
|
|
2022-10-24 |
2022-10-20 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
811
-0.4%
18,01
14 607
USD
|
811
-0.4%
|
18,01
|
14 607
USD
|
|
2022-09-28 |
2022-09-28 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
3 122
-13.1%
15,25
47 610
USD
|
3 122
-13.1%
|
15,25
|
47 610
USD
|
|
2022-09-28 |
2022-09-28 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
3 085
-1.5%
15,23
46 997
USD
|
3 085
-1.5%
|
15,23
|
46 997
USD
|
|
2022-09-28 |
2022-09-27 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
2 403
-10.4%
15,31
36 789
USD
|
2 403
-10.4%
|
15,31
|
36 789
USD
|
|
2022-09-28 |
2022-09-27 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
966
-0.5%
15,82
15 286
USD
|
966
-0.5%
|
15,82
|
15 286
USD
|
|
2022-09-28 |
2022-09-27 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
3 453
-1.6%
15,04
51 934
USD
|
3 453
-1.6%
|
15,04
|
51 934
USD
|
|
2022-09-28 |
2022-09-26 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
300
-1.4%
16,33
4 899
USD
|
300
-1.4%
|
16,33
|
4 899
USD
|
|
2022-09-28 |
2022-09-26 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
2 768
-11.6%
15,22
42 131
USD
|
2 768
-11.6%
|
15,22
|
42 131
USD
|
|
2022-09-28 |
2022-09-26 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
215
-0.3%
16,25
3 493
USD
|
215
-0.3%
|
16,25
|
3 493
USD
|
|
2022-09-28 |
2022-09-26 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
1 329
-2.1%
15,32
20 360
USD
|
1 329
-2.1%
|
15,32
|
20 360
USD
|
|
2022-09-28 |
2022-09-26 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
288
-0.1%
16,30
4 695
USD
|
288
-0.1%
|
16,30
|
4 695
USD
|
|
2022-09-28 |
2022-09-26 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
2 795
-1.3%
15,22
42 530
USD
|
2 795
-1.3%
|
15,22
|
42 530
USD
|
|
2022-09-23 |
2022-09-23 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
1 018
-1.6%
15,07
15 341
USD
|
1 018
-1.6%
|
15,07
|
15 341
USD
|
|
2022-09-23 |
2022-09-23 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
1 023
-0.5%
15,07
15 413
USD
|
1 023
-0.5%
|
15,07
|
15 413
USD
|
|
2022-09-23 |
2022-09-23 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
939
-4.3%
15,09
14 167
USD
|
939
-4.3%
|
15,09
|
14 167
USD
|
|
2022-09-23 |
2022-09-21 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
3 275
-4.8%
15,13
49 537
USD
|
3 275
-4.8%
|
15,13
|
49 537
USD
|
|
2022-09-23 |
2022-09-21 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
3 402
-1.5%
15,12
51 425
USD
|
3 402
-1.5%
|
15,12
|
51 425
USD
|
|
2022-09-23 |
2022-09-21 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
3 341
-13.9%
15,08
50 393
USD
|
3 341
-13.9%
|
15,08
|
50 393
USD
|
|
2022-09-19 |
2022-09-15 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
106
-0.5%
15,01
1 591
USD
|
106
-0.5%
|
15,01
|
1 591
USD
|
|
2022-09-19 |
2022-09-15 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
100
-0.1%
15,01
1 501
USD
|
100
-0.1%
|
15,01
|
1 501
USD
|
|
2022-09-19 |
2022-09-15 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
200
-0.1%
15,04
3 008
USD
|
200
-0.1%
|
15,04
|
3 008
USD
|
|
2022-09-12 |
2022-09-09 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
688
-0.3%
15,07
10 366
USD
|
688
-0.3%
|
15,07
|
10 366
USD
|
|
2022-09-12 |
2022-09-09 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
800
-3.7%
15,07
12 054
USD
|
800
-3.7%
|
15,07
|
12 054
USD
|
|
2022-09-12 |
2022-09-09 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
865
-1.2%
15,06
13 031
USD
|
865
-1.2%
|
15,06
|
13 031
USD
|
|
2022-09-12 |
2022-09-08 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
1 100
-0.5%
15,16
16 673
USD
|
1 100
-0.5%
|
15,16
|
16 673
USD
|
|
2022-09-12 |
2022-09-08 |
VP
Vente planifiée
|
KREHER NERISSA
Chief Medical Officer
Dirigeant
|
1 221
-5.6%
15,13
18 478
USD
|
1 221
-5.6%
|
15,13
|
18 478
USD
|
|
2022-09-12 |
2022-09-08 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
912
-1.3%
15,15
13 814
USD
|
912
-1.3%
|
15,15
|
13 814
USD
|
|
2022-08-31 |
2022-08-31 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
171
-0.1%
12,00
2 052
USD
|
171
-0.1%
|
12,00
|
2 052
USD
|
|
2022-08-31 |
2022-08-30 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
190
-0.1%
12,00
2 280
USD
|
190
-0.1%
|
12,00
|
2 280
USD
|
|
2022-08-31 |
2022-08-29 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
25
-0.0%
14,00
350
USD
|
25
-0.0%
|
14,00
|
350
USD
|
|
2022-08-31 |
2022-08-29 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
505
-0.2%
13,51
6 822
USD
|
505
-0.2%
|
13,51
|
6 822
USD
|
|
2022-08-31 |
2022-08-29 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
1 109
-0.5%
12,56
13 931
USD
|
1 109
-0.5%
|
12,56
|
13 931
USD
|
|
2022-08-26 |
2022-08-25 |
VP
Vente planifiée
|
WENTWORTH KORY JAMES
Chief Financial Officer
Dirigeant
|
1 551
-12.4%
14,18
21 986
USD
|
1 551
-12.4%
|
14,18
|
21 986
USD
|
|
2022-08-26 |
2022-08-24 |
VP
Vente planifiée
|
WENTWORTH KORY JAMES
Chief Financial Officer
Dirigeant
|
301
-2.3%
14,23
4 282
USD
|
301
-2.3%
|
14,23
|
4 282
USD
|
|
2022-08-26 |
2022-08-24 |
VP
Vente planifiée
|
WENTWORTH KORY JAMES
Chief Financial Officer
Dirigeant
|
2 817
-18.0%
13,52
38 093
USD
|
2 817
-18.0%
|
13,52
|
38 093
USD
|
|
2022-08-23 |
2022-08-23 |
VP
Vente planifiée
|
WENTWORTH KORY JAMES
Chief Financial Officer
Dirigeant
|
2 909
-16.7%
13,09
38 080
USD
|
2 909
-16.7%
|
13,09
|
38 080
USD
|
|
2022-08-23 |
2022-08-22 |
VP
Vente planifiée
|
WENTWORTH KORY JAMES
Chief Financial Officer
Dirigeant
|
217
-1.3%
13,00
2 822
USD
|
217
-1.3%
|
13,00
|
2 822
USD
|
|
2022-08-23 |
2022-08-19 |
VP
Vente planifiée
|
WENTWORTH KORY JAMES
Chief Financial Officer
Dirigeant
|
8 529
-34.6%
13,08
111 530
USD
|
8 529
-34.6%
|
13,08
|
111 530
USD
|
|
2022-08-18 |
2022-08-18 |
VP
Vente planifiée
|
WENTWORTH KORY JAMES
Chief Financial Officer
Dirigeant
|
200
-1.0%
13,00
2 600
USD
|
200
-1.0%
|
13,00
|
2 600
USD
|
|
2022-08-18 |
2022-08-17 |
VP
Vente planifiée
|
WENTWORTH KORY JAMES
Chief Financial Officer
Dirigeant
|
200
-1.0%
13,07
2 614
USD
|
200
-1.0%
|
13,07
|
2 614
USD
|
|
2022-08-18 |
2022-08-16 |
VP
Vente planifiée
|
WENTWORTH KORY JAMES
Chief Financial Officer
Dirigeant
|
200
-1.0%
13,00
2 600
USD
|
200
-1.0%
|
13,00
|
2 600
USD
|
|
2022-07-29 |
2022-07-27 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
2 000
-0.9%
12,00
24 000
USD
|
2 000
-0.9%
|
12,00
|
24 000
USD
|
|
2022-06-29 |
2022-06-27 |
VP
Vente planifiée
|
Dowden Nathan J
Chief Operating Officer
Dirigeant
|
7 714
-10.6%
13,00
100 282
USD
|
7 714
-10.6%
|
13,00
|
100 282
USD
|
|
2022-06-29 |
2022-06-27 |
VP
Vente planifiée
|
Doshi Dipal
President and CEO
Administrateur exécutif
|
4 000
-1.9%
12,00
48 000
USD
|
4 000
-1.9%
|
12,00
|
48 000
USD
|
|
2022-06-06 |
2022-06-06 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
26 450
+0.6%
6,42
169 849
USD
|
26 450
+0.6%
|
6,42
|
169 849
USD
|
|
2022-06-06 |
2022-06-06 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
3 118
+0.9%
6,42
20 022
USD
|
3 118
+0.9%
|
6,42
|
20 022
USD
|
|
2022-06-06 |
2022-06-06 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
7 815
+0.2%
6,35
49 654
USD
|
7 815
+0.2%
|
6,35
|
49 654
USD
|
|
2022-06-06 |
2022-06-06 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
921
+0.3%
6,35
5 852
USD
|
921
+0.3%
|
6,35
|
5 852
USD
|
|
2022-06-06 |
2022-06-02 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
2 364
+0.1%
5,82
13 759
USD
|
2 364
+0.1%
|
5,82
|
13 759
USD
|
|
2022-06-06 |
2022-06-02 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
279
+0.1%
5,82
1 624
USD
|
279
+0.1%
|
5,82
|
1 624
USD
|
|
2022-05-24 |
2022-05-24 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
19 789
+0.4%
5,74
113 619
USD
|
19 789
+0.4%
|
5,74
|
113 619
USD
|
|
2022-05-24 |
2022-05-24 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
2 334
+0.7%
5,74
13 401
USD
|
2 334
+0.7%
|
5,74
|
13 401
USD
|
|
2022-05-24 |
2022-05-24 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
1 521
+0.0%
5,93
9 020
USD
|
1 521
+0.0%
|
5,93
|
9 020
USD
|
|
2022-05-24 |
2022-05-24 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
179
+0.1%
5,93
1 061
USD
|
179
+0.1%
|
5,93
|
1 061
USD
|
|
2022-05-24 |
2022-05-23 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
7 010
+0.2%
5,99
41 972
USD
|
7 010
+0.2%
|
5,99
|
41 972
USD
|
|
2022-05-24 |
2022-05-23 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
827
+0.2%
5,99
4 952
USD
|
827
+0.2%
|
5,99
|
4 952
USD
|
|
2022-05-24 |
2022-05-20 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
7 772
+0.2%
5,84
45 405
USD
|
7 772
+0.2%
|
5,84
|
45 405
USD
|
|
2022-05-24 |
2022-05-20 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
946
+0.3%
5,84
5 527
USD
|
946
+0.3%
|
5,84
|
5 527
USD
|
|
2022-05-24 |
2022-05-20 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
7 248
+0.2%
5,84
42 335
USD
|
7 248
+0.2%
|
5,84
|
42 335
USD
|
|
2022-05-24 |
2022-05-20 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
883
+0.2%
5,84
5 158
USD
|
883
+0.2%
|
5,84
|
5 158
USD
|
|
2022-05-18 |
2022-05-18 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
30 003
+0.7%
6,00
180 018
USD
|
30 003
+0.7%
|
6,00
|
180 018
USD
|
|
2022-05-18 |
2022-05-18 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
3 654
+1.0%
6,00
21 924
USD
|
3 654
+1.0%
|
6,00
|
21 924
USD
|
|
2022-05-18 |
2022-05-18 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
692
+0.0%
5,92
4 095
USD
|
692
+0.0%
|
5,92
|
4 095
USD
|
|
2022-05-18 |
2022-05-18 |
A
Achat
|
BAKER BROS. ADVISORS LP
Large shareholder
|
84
+0.0%
5,92
497
USD
|
84
+0.0%
|
5,92
|
497
USD
|
|